Investment in Boost Health: Implementing 'Reproducible Talent Success' through AI and Psychological Science

Genesia Ventures, Inc. (Representative Director: Soichi Tajima, Headquarters: Shibuya-ku, Tokyo) is pleased to announce its investment in the seed round of Boost Health, Inc. (CEO: Ayaka Haga, Headquarters: Minato-ku, Tokyo), a company providing "BOOST," a service that implements the next-generation management model known as "Talent Success." Other investors in this round include WPower Fund, Incubate Fund, and DG Incubation.

Background of the Investment

As the adoption of AI accelerates, the role of human talent in corporations is undergoing a major shift. With routine tasks being automated, individuals are increasingly required to exercise autonomous judgment and creative problem-solving. Consequently, corporate competitiveness is shifting toward the ability to cultivate talent capable of achieving results autonomously with high reproducibility.

While investments in "management structures" such as organizational design and evaluation systems have progressed, there has been insufficient investment in "talent success support"—the assistance required for existing employees to achieve results autonomously. Individualized support from excellent managers is often idiosyncratic and difficult to replicate, while traditional training programs, though scalable, lack the necessary individual optimization.

Boost Health defines "Talent Success" as a framework that simultaneously satisfies three elements: "Quality of intervention/support (Q)," "Personalization (P)," and "Reproducibility (R)." This represents a new management domain that transcends traditional "talent development" and "engagement" frameworks to achieve the "reproducibility of talent success." We invested in the company because we resonate with their approach of tackling the issue of idiosyncratic talent support by combining AI, psychological science, and professional coaching.

Business Overview

Boost Health provides "BOOST," a corporate talent success service that combines AI tools based on psychological sciences like cognitive behavioral therapy with monthly interventions by professional coaches.

The AI tool provides 365-day support to each employee, ensuring personalization (P) and reproducibility (R), while professional coaches address the deeper cognitive aspects that AI cannot reach, thereby raising the quality (Q) of the intervention. By designing a system where AI and humans complement each other's limitations, the company enhances the reproducibility of talent success within organizations. A key feature is its ability to go beyond traditional training and surveys to drive "daily behavioral change."

Effectiveness verification at multiple client companies (joint research with Iori Egawa of Senshu University Graduate School) showed that employees using BOOST for three months saw an average 8-point improvement in productivity metrics (statistically significant). Additionally, 71% of high-stress individuals showed stress improvement, and one company reported a 13% increase in engagement. At Dentsu Inc., condition scores for employees after transfers improved by 47%, and Hitachi, Ltd. began test implementation of the model for autonomous talent development in large-scale organizations in 2026.

Use of Funds and Future Outlook

The total of 150 million yen raised will be used for the following purposes:

• Advancement of AI products and strengthening of data infrastructure
• Strengthening of implementation support systems for enterprise companies

Furthermore, BOOST is currently working on measuring the ROI of human capital investment.